We've found
13,253
archived clinical trials in
Arthritis
We've found
13,253
archived clinical trials in
Arthritis
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
Updated: 7/19/2012
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated: 7/19/2012
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
Updated: 7/19/2012
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated: 7/19/2012
Click here to add this to my saved trials
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
Updated: 7/19/2012
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated: 7/19/2012
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
Updated: 7/19/2012
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated: 7/19/2012
Click here to add this to my saved trials
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
Updated: 7/19/2012
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated: 7/19/2012
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
Updated: 7/19/2012
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated: 7/19/2012
Click here to add this to my saved trials
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
Updated: 7/19/2012
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated: 7/19/2012
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
Updated: 7/19/2012
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated: 7/19/2012
Click here to add this to my saved trials
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
Updated: 7/19/2012
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated: 7/19/2012
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
Updated: 7/19/2012
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated: 7/19/2012
Click here to add this to my saved trials
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
Updated: 7/19/2012
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated: 7/19/2012
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
Updated: 7/19/2012
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated: 7/19/2012
Click here to add this to my saved trials
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
Updated: 7/19/2012
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated: 7/19/2012
Efficacy and Safety of FLOSEAL for Hemostasis in Total Knee Arthroplasty
Updated: 7/19/2012
A Prospective, Randomized, Controlled, Single-Blinded, Multicenter Study to Evaluate the Efficacy and Safety of FLOSEAL for Hemostasis in Primary Unilateral Total Knee Arthroplasty (TKA)
Status: Enrolling
Updated: 7/19/2012
Click here to add this to my saved trials
Draining PLN and Synovial Inflammation in RA Knee Joints Pre and Post Anti-TNF or B Cell Depletion Therapy
Updated: 7/27/2012
The Morphologic and Functional Relationship Between the Draining PLN and Synovial Inflammation in the Knee Joints of RA Patients Before and After Anti-TNF or B Cell Depletion Therapy
Status: Enrolling
Updated: 7/27/2012
Draining PLN and Synovial Inflammation in RA Knee Joints Pre and Post Anti-TNF or B Cell Depletion Therapy
Updated: 7/27/2012
The Morphologic and Functional Relationship Between the Draining PLN and Synovial Inflammation in the Knee Joints of RA Patients Before and After Anti-TNF or B Cell Depletion Therapy
Status: Enrolling
Updated: 7/27/2012
Click here to add this to my saved trials
Prediction of Response to Intra-articular Injections of Hyaluronic Acid for Knee Osteoarthritis
Updated: 8/1/2012
Prediction of Response to Intra-articular Injections of Hyaluronic Acid for Knee Osteoarthritis
Status: Enrolling
Updated: 8/1/2012
Prediction of Response to Intra-articular Injections of Hyaluronic Acid for Knee Osteoarthritis
Updated: 8/1/2012
Prediction of Response to Intra-articular Injections of Hyaluronic Acid for Knee Osteoarthritis
Status: Enrolling
Updated: 8/1/2012
Click here to add this to my saved trials
Prediction of Response to Intra-articular Injections of Hyaluronic Acid for Knee Osteoarthritis
Updated: 8/1/2012
Prediction of Response to Intra-articular Injections of Hyaluronic Acid for Knee Osteoarthritis
Status: Enrolling
Updated: 8/1/2012
Prediction of Response to Intra-articular Injections of Hyaluronic Acid for Knee Osteoarthritis
Updated: 8/1/2012
Prediction of Response to Intra-articular Injections of Hyaluronic Acid for Knee Osteoarthritis
Status: Enrolling
Updated: 8/1/2012
Click here to add this to my saved trials
Patient and Provider Interventions for Managing Osteoarthritis in Primary Care
Updated: 8/10/2012
Patient and Provider Interventions for Managing Osteoarthritis in Primary Care
Status: Enrolling
Updated: 8/10/2012
Patient and Provider Interventions for Managing Osteoarthritis in Primary Care
Updated: 8/10/2012
Patient and Provider Interventions for Managing Osteoarthritis in Primary Care
Status: Enrolling
Updated: 8/10/2012
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Updated: 8/23/2012
Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients
Status: Enrolling
Updated: 8/23/2012
Click here to add this to my saved trials
Impact Of RA Therapy Compliance On Patient-Reported Outcomes
Updated: 9/4/2012
Impact Of RA Therapy Compliance On Patient-Reported Outcomes
Status: Enrolling
Updated: 9/4/2012
Impact Of RA Therapy Compliance On Patient-Reported Outcomes
Updated: 9/4/2012
Impact Of RA Therapy Compliance On Patient-Reported Outcomes
Status: Enrolling
Updated: 9/4/2012
Click here to add this to my saved trials
Gait Analysis of Anterior Versus Posterior Approach in Performance of Total Hip Arthroplasty
Updated: 9/5/2012
Gait Analysis of Anterior vs. Posterior Approach in Performance of Total Hip Arthroplasty: A Multi-Centre, Prospective Trial
Status: Enrolling
Updated: 9/5/2012
Gait Analysis of Anterior Versus Posterior Approach in Performance of Total Hip Arthroplasty
Updated: 9/5/2012
Gait Analysis of Anterior vs. Posterior Approach in Performance of Total Hip Arthroplasty: A Multi-Centre, Prospective Trial
Status: Enrolling
Updated: 9/5/2012
Click here to add this to my saved trials
Gait Analysis of Anterior Versus Posterior Approach in Performance of Total Hip Arthroplasty
Updated: 9/5/2012
Gait Analysis of Anterior vs. Posterior Approach in Performance of Total Hip Arthroplasty: A Multi-Centre, Prospective Trial
Status: Enrolling
Updated: 9/5/2012
Gait Analysis of Anterior Versus Posterior Approach in Performance of Total Hip Arthroplasty
Updated: 9/5/2012
Gait Analysis of Anterior vs. Posterior Approach in Performance of Total Hip Arthroplasty: A Multi-Centre, Prospective Trial
Status: Enrolling
Updated: 9/5/2012
Click here to add this to my saved trials
Gait Analysis of Anterior Versus Posterior Approach in Performance of Total Hip Arthroplasty
Updated: 9/5/2012
Gait Analysis of Anterior vs. Posterior Approach in Performance of Total Hip Arthroplasty: A Multi-Centre, Prospective Trial
Status: Enrolling
Updated: 9/5/2012
Gait Analysis of Anterior Versus Posterior Approach in Performance of Total Hip Arthroplasty
Updated: 9/5/2012
Gait Analysis of Anterior vs. Posterior Approach in Performance of Total Hip Arthroplasty: A Multi-Centre, Prospective Trial
Status: Enrolling
Updated: 9/5/2012
Click here to add this to my saved trials
Gait Analysis of Anterior Versus Posterior Approach in Performance of Total Hip Arthroplasty
Updated: 9/5/2012
Gait Analysis of Anterior vs. Posterior Approach in Performance of Total Hip Arthroplasty: A Multi-Centre, Prospective Trial
Status: Enrolling
Updated: 9/5/2012
Gait Analysis of Anterior Versus Posterior Approach in Performance of Total Hip Arthroplasty
Updated: 9/5/2012
Gait Analysis of Anterior vs. Posterior Approach in Performance of Total Hip Arthroplasty: A Multi-Centre, Prospective Trial
Status: Enrolling
Updated: 9/5/2012
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of MEDI5117 in Rheumatoid Arthritis Patients
Updated: 9/10/2012
A Double-blind, Placebo-controlled, Randomized Study in Rheumatoid Arthritis Subjects to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of MEDI5117 (Anti-IL-6)
Status: Enrolling
Updated: 9/10/2012
Study to Assess the Safety and Tolerability of MEDI5117 in Rheumatoid Arthritis Patients
Updated: 9/10/2012
A Double-blind, Placebo-controlled, Randomized Study in Rheumatoid Arthritis Subjects to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of MEDI5117 (Anti-IL-6)
Status: Enrolling
Updated: 9/10/2012
Click here to add this to my saved trials
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
Updated: 9/14/2012
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
Updated: 9/14/2012
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Click here to add this to my saved trials
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
Updated: 9/14/2012
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
Updated: 9/14/2012
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Click here to add this to my saved trials
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
Updated: 9/14/2012
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
Updated: 9/14/2012
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Click here to add this to my saved trials
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
Updated: 9/14/2012
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
Updated: 9/14/2012
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Click here to add this to my saved trials
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
Updated: 9/14/2012
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
Updated: 9/14/2012
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Click here to add this to my saved trials
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
Updated: 9/14/2012
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
Updated: 9/14/2012
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Click here to add this to my saved trials
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
Updated: 9/14/2012
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
Updated: 9/14/2012
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Click here to add this to my saved trials
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
Updated: 9/14/2012
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
Updated: 9/14/2012
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Click here to add this to my saved trials
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
Updated: 9/14/2012
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
Updated: 9/14/2012
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Click here to add this to my saved trials
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
Updated: 9/14/2012
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
Updated: 9/14/2012
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Click here to add this to my saved trials
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
Updated: 9/14/2012
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
Updated: 9/14/2012
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Click here to add this to my saved trials
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
Updated: 9/14/2012
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
Updated: 9/14/2012
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Click here to add this to my saved trials
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
Updated: 9/14/2012
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
Updated: 9/14/2012
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Click here to add this to my saved trials
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
Updated: 9/14/2012
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
Updated: 9/14/2012
OSKIRA-ABPM: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Effect of Fostamatinib 100 mg Twice Daily on 24-hour Ambulatory Blood Pressure in Patients With Rheumatoid Arthritis
Status: Enrolling
Updated: 9/14/2012
Click here to add this to my saved trials